Evidence map›Paper›PMID 31303849›Full record

ReviewThe Malaysian journal of medical sciences : MJMS2019

Prevalence of HIV, Hepatitis B and C Virus Co-infections among Iranian High-Risk Groups: A Systematic Review and Meta-Analysis.

Amir Almasi Hashiani, Farzin Sadeghi, Erfan Ayubi, Shahab Rezaeian, Yousef Moradi, Kamyar Mansori, Behzad Gholamaliei, Abolfazl Mohammadbeigi, Salman Khazaei

Open access · diamondAbstract readReview
In one paragraph

Review in The Malaysian journal of medical sciences : MJMS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. The frequency, related cause of disease, and treatment of hepatitis B virus infection: A systematic review and meta-analysis in Iran.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Amir Almasi HashianiDepartment of Epidemiology, Arak University of Medical Sciences, Arak, Iran and Traditional and Complementary Medicine Research Center, Arak University of Medical Sciences, Arak, Iran.
Farzin SadeghiInfectious Diseases & Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran.
Erfan AyubiDepartment of Community Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Shahab RezaeianResearch Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Yousef MoradiPars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran.
Kamyar MansoriDepartment of Epidemiology and Biostatistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Behzad GholamalieiDepartment of Public Health, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Abolfazl MohammadbeigiResearch Center of Gastroenterology and Hepatology, Qom University of Medical Sciences, Qom, Iran.
Salman KhazaeiResearch Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IRArak University of Medical Sciences · IRBabol University of Medical Sciences · IRIran University of Medical Sciences · IRKermanshah University of Medical Sciences · IRQom University of Medical Science and Health Services · IRZahedan University of Medical Sciences · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co-infection with hepatitis B and C among HIV infected patients are prevalent among high-risk populations. This meta-analysis aimed to estimate the prevalence of HIV, HCV and HBV co-infections among high-risk populations in Iran. We systematically searched the national and international electronic databases until 2016. The primary outcome was the prevalence of HIV, HBV, HCV and HIV co-infections in different high-risk populations in Iran. All English and Persian studies conducted on Iranian high-risk groups were included in the study. The review was reported based on PRISMA guidelines and data were analysed at 95% confidence level using random effect models. Overall, 916 relevant papers were recognised and 14 articles were included in the meta-analysis. The pooled estimates of HBV/HCV, HCV/HIV, HBV/HIV and HBV/HCV/HIV were 1.3% (95%CI: 0.5-2.1), 16.3% (95%CI: 1.1-31.6), 0.5% (95%CI: 0-1.4) and 0.5% (95%CI: 0.2-0.8), respectively. Based on subgroup analysis, there was a higher proportion of all co-infections from the years 2010-2016 as compared to that of the years 2003-2009. Our results highlighted that HCV/HIV co-infection in Iranian high-risk groups including injection drug users (IDUs) and prisoners is common. In addition, the increasing trend of coinfections should be considered alarming for policymakers.

Indexed as

co-infectionhepatitis Bhepatitis CHIV infection

Identifiers

PMID31303849
PMCPMC6613465
OpenAlexW2954189019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.